Is the extension of adjuvant hormone therapy for breast cancer justified?

by V. F. Semiglazov, V. S. Apollonova
Published 2020-07-01

New prospects in the use of Kadcyla® in breast cancer

by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, R. M. Paltuev, E. E. Topuzov, T. Yu. Semiglazova, E. K. Zhil’tsova, R. V. Donskikh, T. T. Tabagua, V. S. Apollonova
Published 2015-11-01

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Published 2016-06-01

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER

by V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov
Published 2018-07-01

Immunology and immunotherapy in the complex treatment of malignant tumors

by V. F. Semiglazov, A. I. Tseluiko, I. A. Baldueva, T. L. Nekhaeva, A. S. Artemyeva, A. G. Kudaybergenova, S. A. Protsenko, A. V. Novik, V. V. Semiglazov, R. V. Donskikh, T. Yu. Semiglazova, R. S. Pesotskiy, V. S. Apollonova, P. V. Krivorotko, A. M. Belyaev
Published 2021-04-01